Seong-jung Kim Australasian Melanoma Conference 2026

Abstracts this author is presenting:

• Phase 2, multicenter, single-arm study of belvarafenib in combination with cobimetinib in patients with locally advanced or metastatic neuroblastoma-RAS mutant melanoma   — Poster Session 2